RHYTHM Biosciences Ltd
Research RHYTHM Biosciences Ltd (RHY) on Bullrun: market cap AUD 29.02M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRHY
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyAUD
- Market capAUD 29.02M
- Financial periodFY2025
Valuation Snapshot
latest market cap is AUD 29.02M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | -0.01 | n/a | n/a | n/a |
| FY2024 | n/a | -AUD 6.86M | -AUD 6.22M | n/a | -0.03 | AUD 709.50K | AUD 163.82K | AUD 867.17K |
| FY2023 | n/a | -AUD 8.22M | -AUD 7.06M | n/a | -0.04 | AUD 4.12M | AUD 84.61K | AUD 5.87M |
| FY2022 | n/a | -AUD 8.79M | -AUD 6.52M | n/a | -0.04 | AUD 7.55M | AUD 170.14K | AUD 7.37M |
| FY2021 | n/a | -AUD 6.61M | -AUD 5.47M | n/a | n/a | AUD 2.23M | n/a | AUD 1.71M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-27 | AUD 29.02M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About RHYTHM Biosciences Ltd
Rhythm Biosciences Limited, a medical diagnostics company, develops and commercialises medical diagnostic tests for cancer detection in Australia and the United States. The company offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. Rhythm Biosciences Limited was incorporated in 2017 and is headquartered in Parkville, Australia.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is RHYTHM Biosciences Ltd's market cap?
RHYTHM Biosciences Ltd's market capitalization is AUD 29.02M.
What does RHYTHM Biosciences Ltd do?
Rhythm Biosciences Limited, a medical diagnostics company, develops and commercialises medical diagnostic tests for cancer detection in Australia and the United States. The company offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. Rhythm Biosciences Limited was incorporated in 2017 and is headquartered in Parkville, Australia.